Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.04.29
关于深圳市多普乐实业生长有限公司业绩允许实现情形说明的鉴证报告(2019年度)
2020.04.29
关于公司前期会计过失更正的专项报告
2020.04.29
关于深圳市多普乐实业生长有限公司2019年度业绩允许完成情形的说明
2020.04.29
关于公司召募资金年度存放与现实使用情形的鉴证报告
2020.04.29
内部控制审计报告
2020.04.29
关于前期会计过失更正及追溯调解的通告
2020.04.29
2019年度商誉减值测试报告
2020.04.29
中天堂富证券有限公司关于公司2019年度召募资金存放与使用情形的专项核查意见
2020.04.29
2019年度召募资金存放与使用情形的专项报告
2020.04.21
关于参股子公司拟生意资产并实现资产境外上市的通告
第一页
上一页
35
36
37
38
39
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】